Top 10 CGT Startups in Asia to Watch in 2025

Asia’s cell and gene therapy (CGT) landscape is entering a new era. From next-gen NK cell platforms to AI-driven cell engineering, a wave of bold startups is transforming how therapies are discovered, developed, and delivered across the region.

These 10 rising players are not only building powerful pipelines but also shaping the future of CGT in Asia - with fresh clinical data, major funding rounds, and strategic partnerships. Whether it’s allogeneic innovation, regulatory T-cell science, or regional manufacturing scale-up, they’re setting the tone for what’s next.‍